Kelly D. Deck, C.P.A.

Kelly D. Deck, C.P.A.

Chief Financial OfficeratInhibrx Biosciences· In proxies 2023–2025

Pay in FY2025Inhibrx Biosciences stock +413.0% the same year

Kelly D. Deck, C.P.A. was paid $923.7K in FY2025 (Dec). Inhibrx Biosciences stock rose 413.0% that year.

Pay$100 in the stock at the end of FY24 → $513
Pay is from the Summary Compensation Table of each Inhibrx Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inhibrx BiosciencesPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +351%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?